USPTO USPTO 2000 CANCELLED - SECTION 8

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die US-Marke wurde als Bildmarke am 16.06.2000 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 24.09.2002 im Markenregister eingetragen. Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".

Markendetails Letztes Update: 02. August 2019

Markenform Bildmarke
Aktenzeichen 76075378
Registernummer 2623068
Anmeldedatum 16. Juni 2000
Veröffentlichungsdatum 02. Juli 2002
Eintragungsdatum 24. September 2002

Markeninhaber

8 rue des Freres Lumiere
63100 CLERMOND-FERRAND
FR

Markenvertreter

Waren und Dienstleistungen

1 Chemicals for use in the manufacture of photographic materials, namely, paints, wetting agents, fixing agents, developing agents, and stabilizers; chemicals for use in the manufacture of paints, dyes, colorings, cosmetics, glues, and surfactants; chemicals for use in the manufacture of horticultural materials, namely, soil preparation agents and fertilizers; chemicals for use in the manufacture of hormones, peptides, enzymes, proteins in the nature of growth hormones for plants, animals and microbes and growth inhibitors and regulators; chemicals for use in the manufacture of diagnostic reagents, cell culture media, cell regulatory agents, amino acids, DNA fragments, RNA fragments, DNA probes, RNA probes, genetic cloning materials, and genetic expression amplifiers
3 Proteins for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, collagen, serum albumin, RNA, DNA and their extracts, amino acids, ribosomes, ceramides, immunostimulating or in imunoregulatory hormones, all obtained from plants; and enzymes for use as ingredients in skin lotions, oils and creams; for use as ingredients in sun tan lotions, oils and creams; for use as ingredients in skin hydrating lotions, oils and creams, namely, proteases, hydrolases, lipases, deshydroxylases and cellulases, all obtained from plants
5 Pharmaceutical preparations for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; veterinary preparations for the treatment of rabies, obesity, auto-immune diseases, namely, feline immunodeficiency virus and simian immunodeficiency virus, in livestock, domestic pets and wild animals, namely foxes and rodents; acaricides, algaecides, biopesticides, herbicides, insecticides, miticides, pesticides and weed killers for agricultural, domestic or commercial use; pharmaceutical preparations produced from plants or containing proteins produced from plants, for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; therapeutic proteins, hormones, peptides and their complexes, derivatives and cofactors, namely, human serum albumin, lactoferrin, hemoglobin, collagen and procollagen for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies; vaccines including antibodies or glycoproteins, namely, glycoprotein G, lipases, namely, gastric lipase, pancreatic lipase; and medicines and pharmaceutical preparations obtained from genetically modified plants or containing the extracts of genetically modified plants for use in the treatment of cystic fibrosis, obesity, emphysema, hemoglobin insufficiency, blood oxygen insufficiency, albumin insufficiency, collagen insufficiency, auto-immune diseases, namely human immunodeficiency virus and multiple sclerosis, iron insufficiency and rabies
42 Biological and biotechnological laboratory research services, namely genetic modification of plants and plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings, biological and biochemical analysis of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research in the field of in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biological laboratory services in the field of in-vitro reproduction and regeneration of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research in the area of field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; biological laboratory services in the area of field and greenhouse reproduction of genetically modified plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings; laboratory research and tests regarding genetically modified plants; laboratory research featuring the expression of therapeutic, cosmetic or nutritional proteins or protein fragments through genetic modification, regeneration, and reproduction of plants, plant cells, embryos, cals, seeds, pollen, leaves, stems and cuttings
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

ID: 1376075378